Permanently Discontinued

EVOTAZ

BRISTOL-MYERS SQUIBB CANADA

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is EVOTAZ discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that EVOTAZ 300MG 150MG has been permanently discontinued (last updated September 22, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is EVOTAZ not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength300MG 150MG

Last updated2017-09-22

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02446731

Strength

300MG 150MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ATAZANAVIR Cobicistat

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2017-09-22

Permanently Discontinued

Business reasons

Other Products from BRISTOL-MYERS SQUIBB CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ABRAXANE FOR INJECTABLE SUSPENSION

100MG · DIN 02281066

BARACLUDE

0.5MG · DIN 02282224

BREYANZI

120000000CELLS · DIN 02527138

CAMZYOS

15MG · DIN 02532573

CAMZYOS

10MG · DIN 02532565

CAMZYOS

2.5MG · DIN 02532549